Ferenc Fenyvesi
Ferenc Fenyvesi
Verified email at
Cited by
Cited by
Evaluation of the cytotoxicity of β-cyclodextrin derivatives: Evidence for the role of cholesterol extraction
T Kiss, F Fenyvesi, I Bácskay, J Váradi, E Fenyvesi, R Iványi, L Szente, ...
European journal of pharmaceutical sciences 40 (4), 376-380, 2010
Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer
Z Ujhelyi, F Fenyvesi, J Váradi, P Fehér, T Kiss, S Veszelka, M Deli, ...
European Journal of Pharmaceutical Sciences 47 (3), 564-573, 2012
Cyclodextrins in drug delivery systems and their effects on biological barriers
Á Haimhoffer, Á Rusznyák, K Réti-Nagy, G Vasvári, J Váradi, ...
Scientia Pharmaceutica 87 (4), 33, 2019
“Back to the future”: a new look at hydroxypropyl beta-cyclodextrins
M Malanga, J Szemán, É Fenyvesi, I Puskás, K Csabai, G Gyémánt, ...
Journal of pharmaceutical sciences 105 (9), 2921-2931, 2016
Cyclodextrins, blood–brain barrier, and treatment of neurological diseases
M Vecsernyés, F Fenyvesi, I Bácskay, MA Deli, L Szente, É Fenyvesi
Archives of medical research 45 (8), 711-729, 2014
Raft and cytoskeleton associations of an ABC transporter: P‐glycoprotein
Z Bacso, H Nagy, K Goda, L Bene, F Fenyvesi, J Matkó, G Szabó
Cytometry Part A: The Journal of the International Society for Analytical …, 2004
P-glycoprotein inhibition by membrane cholesterol modulation
F Fenyvesi, E Fenyvesi, L Szente, K Goda, Z Bacsó, I Bácskay, J Váradi, ...
European journal of pharmaceutical sciences 34 (4-5), 236-242, 2008
Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis
F Fenyvesi, K Réti-Nagy, Z Bacsó, Z Gutay-Tóth, M Malanga, É Fenyvesi, ...
PloS one 9 (1), e84856, 2014
Evaluation of the cytotoxicity of α-cyclodextrin derivatives on the caco-2 cell line and human erythrocytes
E Róka, Z Ujhelyi, M Deli, A Bocsik, É Fenyvesi, L Szente, F Fenyvesi, ...
Molecules 20 (11), 20269-20285, 2015
Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody
K Goda, F Fenyvesi, Z Bacso, H Nagy, T Marian, A Megyeri, Z Krasznai, ...
Journal of Pharmacology and Experimental Therapeutics 320 (1), 81-88, 2007
Endocytosis of fluorescent cyclodextrins by intestinal Caco-2 cells and its role in paclitaxel drug delivery
K Réti-Nagy, M Malanga, É Fenyvesi, L Szente, G Vámosi, J Váradi, ...
International Journal of Pharmaceutics 496 (2), 509-517, 2015
Physico-chemical characterization of self-emulsifying drug delivery systems
Z Ujhelyi, M Vecsernyés, P Fehér, D Kósa, P Arany, D Nemes, D Sinka, ...
Drug Discovery Today: Technologies 27, 81-86, 2018
Antioxidant and hepatoprotective activity of milk thistle (Silybum marianum L. Gaertn.) seed oil
A Hermenean, M Stan, A Ardelean, L Pilat, CV Mihali, C Popescu, L Nagy, ...
Open life sciences 10 (1), 2015
Role of cytotoxicity experiments in pharmaceutical development
I Bácskay, D Nemes, F Fenyvesi, J Váradi, G Vasvári, P Fehér, ...
Cytotoxicity 8, 131-46, 2018
Efficacy of Pre- and Post-Treatment by Topical Formulations Containing Dissolved and Suspended Silybum marianum against UVB-Induced Oxidative Stress in …
P Fehér, Z Ujhelyi, J Váradi, F Fenyvesi, E Róka, B Juhász, B Varga, ...
Molecules 21 (10), 1269, 2016
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies
H Nagy, K Goda, F Fenyvesi, Z Bacsó, M Szilasi, J Kappelmayer, ...
Biochemical and biophysical research communications 315 (4), 942-949, 2004
Cyclodextrin complexation improves the solubility and Caco-2 permeability of chrysin
F Fenyvesi, TLP Nguyen, Á Haimhoffer, Á Rusznyák, G Vasvári, I Bácskay, ...
Materials 13 (16), 3618, 2020
Matrix systems for oral drug delivery: Formulations and drug release
G Vasvári, J Kalmár, P Veres, M Vecsernyés, I Bácskay, P Fehér, Z Ujhelyi, ...
Drug Discovery Today: Technologies 27, 71-80, 2018
Randomly methylated β‐cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco‐2 cell monolayer
F Fenyvesi, T Kiss, É Fenyvesi, L Szente, S Veszelka, MA Deli, J Váradi, ...
Journal of pharmaceutical sciences 100 (11), 4734-4744, 2011
The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer HeLa cells
Z Ujhelyi, A Kalantari, M Vecsernyés, E Róka, F Fenyvesi, R Póka, ...
Molecules 20 (7), 13226-13239, 2015
The system can't perform the operation now. Try again later.
Articles 1–20